US Stock MarketDetailed Quotes

Corvus Pharmaceuticals (CRVS)

Watchlist
  • 12.440
  • -1.215-8.90%
Trading May 15 15:56 ET
1.05BMarket Cap-22.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corvus Pharmaceuticals (CRVS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.55%-10.37M
-29.00%-32.8M
-8.58%-9.19M
-51.34%-9.57M
-5.40%-5.78M
-60.23%-8.26M
-6.22%-25.42M
-63.83%-8.47M
-16.32%-6.32M
-4.94%-5.48M
Net income from continuing operations
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Operating gains losses
102.44%599K
-168.86%-25.18M
-84.34%707K
-99.04%323K
-30.99%-1.62M
-10,319.49%-24.59M
592.07%36.57M
221.65%4.52M
3,776.07%33.53M
-196.50%-1.24M
Depreciation and amortization
31.82%29K
23.53%105K
30.00%26K
33.33%28K
38.10%29K
-4.35%22K
-43.71%85K
-28.57%20K
-30.00%21K
-41.67%21K
Change In working capital
-62.50%57K
317.30%3.58M
174.30%1.08M
-498.55%-550K
630.83%2.89M
-30.59%152K
54.17%-1.65M
-273.15%-1.46M
121.90%138K
-70.85%-545K
-Change in receivables
-50.00%-6K
177.55%38K
0.00%-5K
254.29%54K
22.22%-7K
---4K
-108.72%-49K
66.67%-5K
-218.18%-35K
-102.10%-9K
-Change in prepaid assets
-250.86%-1.76M
159.29%941K
82.53%-204K
128.70%64K
68.93%-87K
1,290.48%1.17M
-19,737.50%-1.59M
-971.64%-1.17M
-913.64%-223K
-17.65%-280K
-Change in payables and accrued expense
339.80%2.71M
228.82%2.67M
485.39%1.28M
-179.68%-455K
1,922.70%2.97M
-709.73%-1.13M
120.15%812K
146.79%219K
195.81%571K
65.17%-163K
-Change in other current assets
-1,014.12%-777K
120.14%115K
106.68%85K
-182.46%-141K
-65.18%86K
-70.07%85K
-151.53%-571K
-564.60%-1.27M
-44.48%171K
-5.73%247K
-Change in other current liabilities
-432.26%-103K
26.59%-185K
-109.64%-74K
79.19%-72K
79.41%-70K
109.28%31K
79.46%-252K
343.04%768K
-11.97%-346K
-11.84%-340K
Cash from discontinued investing activities
Operating cash flow
-25.55%-10.37M
-29.00%-32.8M
-8.58%-9.19M
-51.34%-9.57M
-5.40%-5.78M
-60.23%-8.26M
-6.22%-25.42M
-63.83%-8.47M
-16.32%-6.32M
-4.94%-5.48M
Investing cash flow
Cash flow from continuing investing activities
-3,513.76%-144.85M
71.63%-7.8M
278.86%10.88M
32.70%-2.62M
-15.98%-20.3M
60,714.29%4.24M
-276.85%-27.48M
-162.42%-6.08M
-122.17%-3.89M
-308.11%-17.5M
Net PPE purchase and sale
-152.78%-91K
-3,580.00%-174K
-600.00%-25K
--0
---113K
---36K
114.71%5K
--5K
--0
--0
Net investment purchase and sale
-3,482.92%-144.76M
72.27%-7.62M
279.12%10.91M
32.70%-2.62M
-15.33%-20.19M
61,228.57%4.28M
-276.49%-27.49M
-162.64%-6.09M
-122.17%-3.89M
-308.11%-17.5M
Cash from discontinued investing activities
Investing cash flow
-3,513.76%-144.85M
71.63%-7.8M
278.86%10.88M
32.70%-2.62M
-15.98%-20.3M
60,714.29%4.24M
-276.85%-27.48M
-162.42%-6.08M
-122.17%-3.89M
-308.11%-17.5M
Financing cash flow
Cash flow from continuing financing activities
68,267.74%190.75M
-25.70%36.43M
-99.89%20K
620.00%360K
17.78%35.77M
279K
524.16%49.03M
18.61M
-85.07%50K
304.07%30.37M
Net common stock issuance
--189.41M
--0
--0
--0
--0
--0
109.17%16.41M
--0
--0
----
Proceeds from stock option exercised by employees
379.93%1.34M
11.67%36.43M
-99.89%20K
620.00%360K
156.14%35.77M
--279K
271,758.33%32.62M
--18.61M
525.00%50K
--13.97M
Cash from discontinued financing activities
Financing cash flow
68,267.74%190.75M
-25.70%36.43M
-99.89%20K
620.00%360K
17.78%35.77M
--279K
524.16%49.03M
--18.61M
-85.07%50K
304.07%30.37M
Net cash flow
Beginning cash position
-47.64%4.58M
-30.74%8.74M
-38.74%2.87M
-1.01%14.69M
-32.95%5M
-30.74%8.74M
-4.10%12.62M
-76.72%4.68M
93.80%14.84M
-22.77%7.46M
Current changes in cash
1,049.64%35.53M
-7.32%-4.16M
-57.91%1.71M
-16.37%-11.82M
31.24%9.69M
27.56%-3.74M
-619.85%-3.88M
154.24%4.06M
-181.63%-10.16M
469.99%7.39M
End cash Position
702.20%40.1M
-47.64%4.58M
-47.64%4.58M
-38.74%2.87M
-1.01%14.69M
-32.95%5M
-30.74%8.74M
-30.74%8.74M
-76.72%4.68M
93.80%14.84M
Free cash flow
-26.10%-10.47M
-29.68%-32.97M
-8.87%-9.22M
-51.34%-9.57M
-7.46%-5.89M
-60.93%-8.3M
-6.07%-25.42M
-63.83%-8.47M
-16.32%-6.32M
-4.94%-5.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.55%-10.37M-29.00%-32.8M-8.58%-9.19M-51.34%-9.57M-5.40%-5.78M-60.23%-8.26M-6.22%-25.42M-63.83%-8.47M-16.32%-6.32M-4.94%-5.48M
Net income from continuing operations -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Operating gains losses 102.44%599K-168.86%-25.18M-84.34%707K-99.04%323K-30.99%-1.62M-10,319.49%-24.59M592.07%36.57M221.65%4.52M3,776.07%33.53M-196.50%-1.24M
Depreciation and amortization 31.82%29K23.53%105K30.00%26K33.33%28K38.10%29K-4.35%22K-43.71%85K-28.57%20K-30.00%21K-41.67%21K
Change In working capital -62.50%57K317.30%3.58M174.30%1.08M-498.55%-550K630.83%2.89M-30.59%152K54.17%-1.65M-273.15%-1.46M121.90%138K-70.85%-545K
-Change in receivables -50.00%-6K177.55%38K0.00%-5K254.29%54K22.22%-7K---4K-108.72%-49K66.67%-5K-218.18%-35K-102.10%-9K
-Change in prepaid assets -250.86%-1.76M159.29%941K82.53%-204K128.70%64K68.93%-87K1,290.48%1.17M-19,737.50%-1.59M-971.64%-1.17M-913.64%-223K-17.65%-280K
-Change in payables and accrued expense 339.80%2.71M228.82%2.67M485.39%1.28M-179.68%-455K1,922.70%2.97M-709.73%-1.13M120.15%812K146.79%219K195.81%571K65.17%-163K
-Change in other current assets -1,014.12%-777K120.14%115K106.68%85K-182.46%-141K-65.18%86K-70.07%85K-151.53%-571K-564.60%-1.27M-44.48%171K-5.73%247K
-Change in other current liabilities -432.26%-103K26.59%-185K-109.64%-74K79.19%-72K79.41%-70K109.28%31K79.46%-252K343.04%768K-11.97%-346K-11.84%-340K
Cash from discontinued investing activities
Operating cash flow -25.55%-10.37M-29.00%-32.8M-8.58%-9.19M-51.34%-9.57M-5.40%-5.78M-60.23%-8.26M-6.22%-25.42M-63.83%-8.47M-16.32%-6.32M-4.94%-5.48M
Investing cash flow
Cash flow from continuing investing activities -3,513.76%-144.85M71.63%-7.8M278.86%10.88M32.70%-2.62M-15.98%-20.3M60,714.29%4.24M-276.85%-27.48M-162.42%-6.08M-122.17%-3.89M-308.11%-17.5M
Net PPE purchase and sale -152.78%-91K-3,580.00%-174K-600.00%-25K--0---113K---36K114.71%5K--5K--0--0
Net investment purchase and sale -3,482.92%-144.76M72.27%-7.62M279.12%10.91M32.70%-2.62M-15.33%-20.19M61,228.57%4.28M-276.49%-27.49M-162.64%-6.09M-122.17%-3.89M-308.11%-17.5M
Cash from discontinued investing activities
Investing cash flow -3,513.76%-144.85M71.63%-7.8M278.86%10.88M32.70%-2.62M-15.98%-20.3M60,714.29%4.24M-276.85%-27.48M-162.42%-6.08M-122.17%-3.89M-308.11%-17.5M
Financing cash flow
Cash flow from continuing financing activities 68,267.74%190.75M-25.70%36.43M-99.89%20K620.00%360K17.78%35.77M279K524.16%49.03M18.61M-85.07%50K304.07%30.37M
Net common stock issuance --189.41M--0--0--0--0--0109.17%16.41M--0--0----
Proceeds from stock option exercised by employees 379.93%1.34M11.67%36.43M-99.89%20K620.00%360K156.14%35.77M--279K271,758.33%32.62M--18.61M525.00%50K--13.97M
Cash from discontinued financing activities
Financing cash flow 68,267.74%190.75M-25.70%36.43M-99.89%20K620.00%360K17.78%35.77M--279K524.16%49.03M--18.61M-85.07%50K304.07%30.37M
Net cash flow
Beginning cash position -47.64%4.58M-30.74%8.74M-38.74%2.87M-1.01%14.69M-32.95%5M-30.74%8.74M-4.10%12.62M-76.72%4.68M93.80%14.84M-22.77%7.46M
Current changes in cash 1,049.64%35.53M-7.32%-4.16M-57.91%1.71M-16.37%-11.82M31.24%9.69M27.56%-3.74M-619.85%-3.88M154.24%4.06M-181.63%-10.16M469.99%7.39M
End cash Position 702.20%40.1M-47.64%4.58M-47.64%4.58M-38.74%2.87M-1.01%14.69M-32.95%5M-30.74%8.74M-30.74%8.74M-76.72%4.68M93.80%14.84M
Free cash flow -26.10%-10.47M-29.68%-32.97M-8.87%-9.22M-51.34%-9.57M-7.46%-5.89M-60.93%-8.3M-6.07%-25.42M-63.83%-8.47M-16.32%-6.32M-4.94%-5.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.26%
Sample Name
Sample Code
 +27.88%
Sample Name
Sample Code
 +26.96%
4
United States Gasoline Fund Lp
UGA
+26.36%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+21.04%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.71%
Sample Name
Sample Code
 +11.02%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.10%
5
Hesai
HSAI
+3.68%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -